Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
IGIV in Cardiac-Associated AL Amyloidosis
NCT00547365Phase 2Completed
- Sponsor
- University of Tennessee
- Start
- Oct 2007
- Primary completion
- Jul 2011
- Modality
- Antibody Conjugates, Recombinant Proteins and Enzymes, Engineered Antibody Formats
- Countries
- 1
01
Overview
A Phase 2 trial of IgPro10 in light-chain amyloidosis, sponsored by University of Tennessee. Started Oct 2007; status: completed.
02
Drugs
IgPro10
03
Conditions
light-chain amyloidosis
Beyond the preview
Go deeper on NCT00547365.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00547365.